Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc.

TRVI
Trevi Therapeutics, Inc.US flagNASDAQ Global Market
13.45
USD
-0.05
- -
1.91BMarket Cap

Income Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
8
18
27
32
32
30
34
52
49
+ Selling, General & Admin
2
4
7
10
9
10
10
12
16
+ Research & Development
6
14
19
22
23
20
24
39
33
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-8
-18
-27
-32
-32
-30
-34
-52
-49
- Non-Operating (Income) Loss
5
2
-1
- -
1
-1
-5
-4
-7
+ Interest Expense, Net
3
- -
-1
- -
1
-1
-4
-4
-7
+ Interest Expense
3
- -
- -
- -
1
1
- -
- -
- -
- Interest Income
- -
- -
1
- -
- -
2
5
4
7
+ Other Non-Op (Income) Loss
1
2
- -
- -
- -
- -
- -
- -
- -
Pretax Income
-13
-21
-26
-33
-34
-29
-29
-48
-43
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-13
-21
-26
-33
-34
-29
-29
-48
-43
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-13
-21
-26
-33
-34
-29
-29
-48
-43
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-13
-21
-26
-33
-34
-29
-29
-48
-43
- Preferred Dividends
4
5
2
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-17
-26
-28
-33
-34
-29
-29
-48
-43
EBIT
-8
-18
-27
-32
-32
-30
-34
-52
-49
EBITDA
-8
-18
-27
-32
-32
-30
-34
-51
-49
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-8
-18
-27
-32
-32
-30
-34
-52
-49
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
9
9
18
19
23
65
99
102
- -
Basic EPS, GAAP
-1.85
-2.89
-1.59
-1.77
-1.49
-0.45
-0.29
-0.47
- -
Basic EPS from Cont Ops
-1.43
-2.29
-1.46
-1.77
-1.49
-0.45
-0.29
-0.47
- -
Diluted Weighted Avg Shares
9
9
18
19
23
65
99
102
- -
Diluted EPS, GAAP
-1.85
-2.89
-1.59
-1.77
-1.49
-0.45
-0.29
-0.47
- -
Diluted EPS from Cont Ops
-1.43
-2.29
-1.46
-1.77
-1.49
-0.45
-0.29
-0.47
- -

Balance Sheet (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
22
9
60
46
38
123
88
109
192
+ Cash, Cash Equivalents & STI
22
7
57
45
37
121
83
108
188
+ Cash & Cash Equivalents
22
7
57
45
37
13
32
34
19
+ ST Investments
- -
- -
- -
- -
- -
108
51
74
169
+ Accounts & Notes Receiv
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
2
1
1
2
5
2
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
2
- -
1
1
- -
2
1
2
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
2
1
1
+ Property, Plant & Equip
- -
- -
1
- -
- -
- -
2
1
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
2
- -
1
- -
- -
- -
- -
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
2
- -
1
- -
- -
- -
- -
1
Total Assets
22
11
60
47
38
123
89
111
193
+ Payables & Accruals
2
2
4
4
5
5
4
8
7
+ Accounts Payable
1
1
2
2
3
3
2
3
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
3
2
3
2
2
4
3
+ ST Debt
5
- -
- -
- -
6
7
- -
- -
- -
+ ST Borrowings
5
- -
- -
- -
6
7
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
1
1
1
2
2
3
3
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
1
1
2
2
3
3
Total Current Liabilities
7
3
5
6
13
13
6
11
10
+ LT Debt
- -
- -
- -
14
9
2
1
1
- -
+ LT Borrowings
- -
- -
- -
14
9
2
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
1
1
- -
+ Other LT Liabilities
- -
2
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
2
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
2
- -
14
9
2
1
1
- -
Total Liabilities
7
4
5
20
21
16
7
11
10
+ Preferred Equity and Hybrid Capital
99
116
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
169
174
198
318
322
387
513
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
169
174
198
318
322
387
513
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-84
-109
-114
-147
-181
-210
-239
-287
-330
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
15
6
55
27
17
107
83
100
183
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
15
6
55
27
17
107
83
100
183
Total Liabilities & Equity
22
11
60
47
38
123
89
111
193
Shares Outstanding
18
18
18
19
29
60
68
94
128
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
1
1
1
Net Debt
-17
-7
-57
-31
-22
-3
-32
-34
-19
Net Debt to Equity
-113.24
-115.27
-105.07
-113.8
-130.86
-3.2
-39.25
-34.22
-10.32
Tangible Common Equity Ratio
-379.83
-1,040.22
90.91
57.89
44.38
87.35
92.33
89.85
94.73
Current Ratio
3.11
3.3
11.45
8.33
2.98
9.15
15.03
10.41
19.66
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-13
-21
-26
-33
-34
-29
-29
-48
-43
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
4
3
1
3
3
2
1
3
4
+ Stock-Based Compensation
- -
- -
1
2
3
2
2
4
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
4
2
- -
- -
1
- -
-2
-1
-1
+ Chg in Non-Cash Work Cap
1
-1
2
1
2
-1
-4
7
-3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
1
- -
-1
-3
3
-1
+ Inc (Dec) in Accts Payable
1
1
2
- -
1
-1
-1
4
-2
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-8
-18
-23
-29
-29
-28
-32
-38
-42
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
-2
64
3
21
105
2
61
108
+ Increase in Capital Stock
- -
- -
65
3
21
105
2
61
108
+ Decrease in Capital Stock
- -
-2
-1
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
-107
60
-21
-94
+ Dec in LT Investment
- -
- -
- -
- -
- -
19
69
77
77
+ Inc in LT Investment
- -
- -
- -
- -
- -
-126
-10
-98
-171
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-107
59
-22
-94
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
-16
-5
- -
14
- -
-6
-19
- -
- -
+ Cash From Debt
- -
- -
- -
14
- -
- -
- -
- -
- -
+ Repayments of Debt
-16
-5
- -
- -
- -
-6
-19
- -
- -
+ Other Financing Activities
38
11
9
- -
- -
12
9
- -
13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
22
4
73
17
21
111
-8
61
121
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
14
-15
50
-12
-8
-24
20
2
-15
EBITDA
-8
-18
-27
-32
-32
-30
-34
-51
-49
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-8
-18
-23
-29
-29
-28
-32
-38
-42
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-13
-141
-15
-29
-34
-51
-38
-42
Free Cash Flow per Basic Share
-0.89
-2.06
-1.3
-1.57
-1.27
-0.44
-0.32
-0.38
- -
Price/Free Cash Flow
- -
- -
-2.9
-1.55
-0.62
-4.45
-4.2
-10.99
- -
Cash Flow to Net Income
0.62
0.89
0.89
0.89
0.85
0.97
1.09
0.8
0.98
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -